DOYLESTOWN, Pa.--(EON: Enhanced Online News)--FlowMetric, a market leader in flow cytometry and cell sorting services, announced today that they have been chosen to join a trade mission led by Philadelphia Mayor, Michael A. Nutter to the United Kingdom in November. For FlowMetric this is an unrivaled opportunity to build on existing partnerships, establish new connections and benefit from the excellent opportunity for growth provided by the U.K.’s investment of over $1 billion per year into clinical research infrastructure and billions more to support cutting edge science.
FlowMetric epitomizes the type of young, vibrant and growing company that looks to be an anchor in any bio-sciences corridor, especially in the flourishing Philadelphia and U.K. bio-sciences eco-systems, where investment and vision have created a thriving life-sciences industry and community that rival any in the world. FlowMetric will complement this community the same way they have achieved their success to date, by focusing on leading-edge technology, drug development expertise and a dedicated services approach.
“We’re delighted to be invited on this mission to exhibit FlowMetric’s capabilities and demonstrate what the Philadelphia life sciences community has to offer. We established our company in Philadelphia because this is the best region for life sciences in the world. To be given an opportunity to develop existing partnerships, create new relationships and explore additional expansion into the U.K., is exciting. Whether it’s funding, support, development and research or serving our clients, this mission offers FlowMetric every opportunity to excel,” said Renold Capocasale, Founder and CEO of FlowMetric.
FlowMetric, Inc. is a nimble and highly-responsive contract research organization (CRO) that provides leading edge flow cytometry techniques, analyses and cell sorting services that combine proprietary assays with advanced analytics to support all stages of drug development and therapeutics for pharmaceutical and biotech companies, research institutions and medical facilities. FlowMetric provides a global reach, an experienced and dedicated team, an unparalleled track record, and an integrated, cost-effective, and specialized methodology to flow cytometry services in both the preclinical and clinical phase of therapeutic development as well as in medical diagnostics. FlowMetric provides drug discovery, analysis and development services that are independent, unbiased, comprehensive, and precise while delivering an uncompromising commitment to quality. FlowMetric is headquartered in the Pennsylvania Biotechnology Center of Bucks County.